Literature DB >> 11786282

Estimate the time varying brain receptor occupancy in PET imaging experiments using non-linear fixed and mixed effect modeling approach.

Stefano Zamuner1, Roberto Gomeni, Alan Bye.   

Abstract

Positron-Emission Tomography (PET) is an imaging technology currently used in drug development as a non-invasive measure of drug distribution and interaction with biochemical target system. The level of receptor occupancy achieved by a compound can be estimated by comparing time-activity measurements in an experiment done using tracer alone with the activity measured when the tracer is given following administration of unlabelled compound. The effective use of this surrogate marker as an enabling tool for drug development requires the definition of a model linking the brain receptor occupancy with the fluctuation of plasma concentrations. However, the predictive performance of such a model is strongly related to the precision on the estimate of receptor occupancy evaluated in PET scans collected at different times following drug treatment. Several methods have been proposed for the analysis and the quantification of the ligand-receptor interactions investigated from PET data. The aim of the present study is to evaluate alternative parameter estimation strategies based on the use of non-linear mixed effect models allowing to account for intra and inter-subject variability on the time-activity and for covariates potentially explaining this variability. A comparison of the different modeling approaches is presented using real data. The results of this comparison indicates that the mixed effect approach with a primary model partitioning the variance in term of Inter-Individual Variability (IIV) and Inter-Occasion Variability (IOV) and a second stage model relating the changes on binding potential to the dose of unlabelled drug is definitely the preferred approach.

Mesh:

Substances:

Year:  2002        PMID: 11786282     DOI: 10.1016/s0969-8051(01)00275-x

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  6 in total

Review 1.  The development, past achievements, and future directions of brain PET.

Authors:  Terry Jones; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

2.  Estimation of drug receptor occupancy when non-displaceable binding differs between brain regions – extending the simplified reference tissue model.

Authors:  Matts Kågedal; Katarina Varnäs; Andrew C Hooker; Mats O Karlsson
Journal:  Br J Clin Pharmacol       Date:  2015-06-01       Impact factor: 4.335

3.  [3H]GR205171 displays similar NK1 receptor binding profile in gerbil and human brain.

Authors:  Cristiana Griffante; Renzo Carletti; Filippo Andreetta; Mauro Corsi
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

4.  A pharmacokinetic PET study of NK₁ receptor occupancy.

Authors:  Stefano Zamuner; Eugenii A Rabiner; Sofia A Fernandes; Massimo Bani; Roger N Gunn; Roberto Gomeni; Emilangelo Ratti; Vincent J Cunningham
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-10-13       Impact factor: 9.236

5.  Simultaneous multifactor Bayesian analysis (SiMBA) of PET time activity curve data.

Authors:  Granville J Matheson; R Todd Ogden
Journal:  Neuroimage       Date:  2022-04-19       Impact factor: 7.400

6.  Pharmacokinetic modeling of P-glycoprotein function at the rat and human blood-brain barriers studied with (R)-[11C]verapamil positron emission tomography.

Authors:  Julia Müllauer; Claudia Kuntner; Martin Bauer; Jens P Bankstahl; Markus Müller; Rob A Voskuyl; Oliver Langer; Stina Syvänen
Journal:  EJNMMI Res       Date:  2012-10-16       Impact factor: 3.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.